Selling More For Less In China Pays Off For AstraZeneca

 
• By Dexter Jie Yan
  
AstraZeneca 2Q China performance
AstraZeneca sees its performance in China resilient despite price cuts. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia